PT1551952T - Seleção e utilização de bactérias do ácido láctico para reduzir a inflamação provocada por helicobacter - Google Patents

Seleção e utilização de bactérias do ácido láctico para reduzir a inflamação provocada por helicobacter

Info

Publication number
PT1551952T
PT1551952T PT37516820T PT03751682T PT1551952T PT 1551952 T PT1551952 T PT 1551952T PT 37516820 T PT37516820 T PT 37516820T PT 03751682 T PT03751682 T PT 03751682T PT 1551952 T PT1551952 T PT 1551952T
Authority
PT
Portugal
Prior art keywords
helicobacter
selection
lactic acid
acid bacteria
reducing inflammation
Prior art date
Application number
PT37516820T
Other languages
English (en)
Inventor
Möllstam Bo
Connolly Eamonn
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of PT1551952T publication Critical patent/PT1551952T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/173—Reuteri
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PT37516820T 2002-10-07 2003-10-06 Seleção e utilização de bactérias do ácido láctico para reduzir a inflamação provocada por helicobacter PT1551952T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/265,859 US7105336B2 (en) 2002-10-07 2002-10-07 Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter

Publications (1)

Publication Number Publication Date
PT1551952T true PT1551952T (pt) 2016-11-23

Family

ID=32042542

Family Applications (1)

Application Number Title Priority Date Filing Date
PT37516820T PT1551952T (pt) 2002-10-07 2003-10-06 Seleção e utilização de bactérias do ácido láctico para reduzir a inflamação provocada por helicobacter

Country Status (14)

Country Link
US (4) US7105336B2 (pt)
EP (1) EP1551952B1 (pt)
JP (2) JP4804755B2 (pt)
KR (2) KR101107453B1 (pt)
CN (1) CN1694954B (pt)
AU (1) AU2003269756B2 (pt)
BR (1) BR0314511A (pt)
DK (1) DK1551952T3 (pt)
ES (1) ES2602679T3 (pt)
HU (1) HUE031627T2 (pt)
MX (1) MXPA05003731A (pt)
PT (1) PT1551952T (pt)
WO (1) WO2004031368A1 (pt)
ZA (1) ZA200502602B (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
MXPA05003743A (es) * 2002-10-18 2005-06-17 Biogaia Ab Metodo para mejorar la funcion inmunologica en mamiferos utilizando cepas de lactobacillus reuteri.
US20050281756A1 (en) 2004-06-14 2005-12-22 Eamonn Connolly Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
AU2004315890A1 (en) * 2003-12-04 2005-09-01 Burwell, Steve Mr. Methods and compositions for preventing biofilm formations, reducing existing biofilms, and for reducing existing biofilms, and for reducing populations of bacteria
KR20060114370A (ko) * 2004-03-04 2006-11-06 이엘씨 매니지먼트 엘엘씨 락토바실러스(Ｌａｃｔｏｂａｃｉｌｌｕｓ) 추출물을이용한 피부 치료 방법
US7955834B2 (en) * 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy
EP1703281A1 (fr) * 2005-03-16 2006-09-20 Compagnie Gervais Danone Souches bactériennes induisant une diminution de l'expression de Rbx1
US7344867B2 (en) * 2005-04-15 2008-03-18 Eamonn Connolly Selection and use of lactic acid bacteria for reducing inflammation in mammals
DE102005062731A1 (de) 2005-12-22 2007-06-28 Organobalance Gmbh Neue Lactobacillus Stämme und deren Verwendung
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
US8603460B2 (en) * 2006-06-05 2013-12-10 Brogaia AB Method of making a Lactobacillus reuteri with increased acid tolerance
CN101678052A (zh) * 2007-02-22 2010-03-24 于尔根·施赖岑米尔 用于在人中预防、抑制或消除变态反应的益生性革兰氏阳性细菌
CN101273736B (zh) * 2007-03-28 2012-08-08 北京弗蒙特生物技术有限公司 一种在常温下保持高活菌数的发酵乳的制备方法
US20080254011A1 (en) * 2007-04-11 2008-10-16 Peter Rothschild Use of selected lactic acid bacteria for reducing atherosclerosis
KR100886793B1 (ko) * 2007-06-26 2009-03-04 한경대학교 산학협력단 항균과 생균 활성을 가지는 신규한락토바실러스　코르니포미스 ｈｄ-０２ 균주 및 이의 용도
CN102115721B (zh) * 2008-05-08 2012-09-26 景岳生物科技股份有限公司 具有抗炎活性的乳杆菌分离株及其用途
US8784798B2 (en) * 2009-05-11 2014-07-22 Nestec S.A. Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders
US20110293710A1 (en) 2010-02-02 2011-12-01 Delphine Saulnier Immunomodulatory properties of lactobacillus strains
WO2013027087A1 (en) 2011-08-23 2013-02-28 Compagnie Gervais Danone A non-reuterin-producing lactobacillus reuteri strain for treating helicobacter pylori infection
WO2013079992A1 (en) * 2011-11-30 2013-06-06 Compagnie Gervais Danone Reuterin-producing lactobacillus brevis
JP2015520773A (ja) * 2012-05-29 2015-07-23 ダヌタ・クルセフスカＤａｎｕｔａＫＲＵＳＺＥＷＳＫＡ ヒトおよび動物における予防および医薬に有用であるラクトバチルス・ロイテリｄａｎ８０を含むナノ製品ならびにこれらの医薬用途
JP2016505239A (ja) 2012-10-25 2016-02-25 コンパニ・ジェルベ・ダノン ヘリコバクター・ピロリ感染症の治療用のストレプトコッカス・サーモフィルス株
EP3040412A4 (en) * 2013-08-23 2017-04-05 Consejo Superior De Investigaciones Científicas (CSIC) Probiotic strain of lactobacillus reuteri exhibiting anti-helicobacter activity, a probiotic or biotherapeutic product comprising said strain, and the use thereof
US10799541B2 (en) 2014-07-01 2020-10-13 Probi USA, Inc. Bi-layer dual release probiotic tablets
CN116396884A (zh) 2022-08-15 2023-07-07 江苏华熙益能生物科技有限公司 鼠李糖乳杆菌和一种抑制幽门螺杆菌的组合物

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5413960A (en) 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
US5458875A (en) 1990-06-15 1995-10-17 Biogaia Ab In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry
US5674901A (en) * 1995-06-01 1997-10-07 Wisconsin Alumni Research Foundation Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations
ATE161181T1 (de) * 1992-07-06 1998-01-15 Nestle Sa Lactobacillus acidophilus enthaltende antigastritis-mittel
WO1994026307A1 (en) * 1993-05-17 1994-11-24 The Picower Institute For Medical Research Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
US6562629B1 (en) * 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US5534253A (en) 1995-06-07 1996-07-09 Biogaia Ab Method of treating enteropathogenic bacterial infections in poultry
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US5837238A (en) 1996-06-05 1998-11-17 Biogaia Biologics Ab Treatment of diarrhea
US6051557A (en) * 1997-05-16 2000-04-18 1149336 Ontario Inc. Methods of enhancing functioning of the upper gastrointestinal tract
WO1999009045A1 (en) * 1997-08-20 1999-02-25 Somagenics, Inc. Antisense and antigene therapeutics with improved binding properties and methods for their use
GB9719238D0 (en) * 1997-09-11 1997-11-12 Mathilda & Terence Kennedy Ins Viral infection of cells
AU2437899A (en) * 1998-02-11 1999-08-30 Neurochem, Inc. Method for modulating macrophage activation
AU4438399A (en) * 1998-06-11 1999-12-30 University Of Medicine And Dentistry Of New Jersey Wound treatment through inhibition of adenosine diphosphate ribosyl transferase
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
JP4509250B2 (ja) * 1999-06-24 2010-07-21 明治乳業株式会社 Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ除菌性医薬品
JP3046303B1 (ja) * 1999-06-24 2000-05-29 明治乳業株式会社 Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ除菌性飲食品
KR100357668B1 (ko) 2000-02-19 2002-10-18 주식회사 한국야쿠르트 헬리코박터 필로리에 대해 항균활성을 갖는 락토바실러스애시도필러스 에이치 와이 2177, 락토바실러스 카제이에이치 와이2743 및 그를 이용한 유산균 제제, 발효유
CA2399550A1 (en) * 2000-02-23 2001-08-30 The Regents Of The University Of California Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
EP1296693A4 (en) * 2000-06-19 2005-05-25 Mucoprotec Pty Ltd IMMUNOTHERAPY AND PROBIOTIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL OR VIRAL INFECTIONS ON MUCOSAL SURFACES
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
AU2002341384A1 (en) * 2001-09-05 2003-03-24 Actial Farmaceutica, Lda. Lactic acid bacteria comprising unmethylated cytosine-guanine dinucleotides for use in therapy
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
US6872565B2 (en) * 2003-01-29 2005-03-29 Biogaia Ab Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries
AU2003303894A1 (en) * 2003-01-30 2004-08-30 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof

Also Published As

Publication number Publication date
JP4804755B2 (ja) 2011-11-02
CN1694954A (zh) 2005-11-09
KR20110033943A (ko) 2011-04-01
KR101064058B1 (ko) 2011-09-08
US7105336B2 (en) 2006-09-12
AU2003269756B2 (en) 2007-08-09
US20100129337A1 (en) 2010-05-27
WO2004031368A1 (en) 2004-04-15
MXPA05003731A (es) 2005-06-17
HUE031627T2 (en) 2017-09-28
EP1551952A1 (en) 2005-07-13
AU2003269756A1 (en) 2004-04-23
JP5439315B2 (ja) 2014-03-12
EP1551952B1 (en) 2016-08-17
JP2011021015A (ja) 2011-02-03
JP2006501823A (ja) 2006-01-19
US7960137B2 (en) 2011-06-14
BR0314511A (pt) 2005-08-09
ES2602679T3 (es) 2017-02-22
US20090110670A1 (en) 2009-04-30
US20060251636A1 (en) 2006-11-09
US20040067573A1 (en) 2004-04-08
KR20050047107A (ko) 2005-05-19
CN1694954B (zh) 2010-05-12
ZA200502602B (en) 2006-06-28
US7678553B2 (en) 2010-03-16
HK1079811A1 (zh) 2006-04-13
KR101107453B1 (ko) 2012-01-19
DK1551952T3 (en) 2016-12-12

Similar Documents

Publication Publication Date Title
PT1551952T (pt) Seleção e utilização de bactérias do ácido láctico para reduzir a inflamação provocada por helicobacter
PL2548455T3 (pl) Kompozycja zawierająca bakterię kwasu mlekowego wytwarzającą ekwol
EP1572262A3 (en) Method of delivering local anesthesia
AU2003284115A1 (en) Method of delivering local anesthesia
EP1660427A4 (en) SUBSTITUTED ARYLALKANIC DERIVATIVE AND ITS USE
AU2003257937A8 (en) Methods and compositions for treatment of dermal conditions
IN2006DE07653A (en) Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
GB0301701D0 (en) Psoriasis and Eicosapentaenoic acid
EP1511488A4 (en) HUMAN INHIBITORS OF ADAM 10
AU2003291700A8 (en) Oral hygiene system and method of treatment
HUS1000019I1 (hu) Karbonsav-tartalmú szerek és növénytermesztésben való alkalmazásuk
AU2003287443A8 (en) Compositions and methods for pain reduction
AU2003290605A8 (en) Compositions and methods for the diagnosis and treatment of sepsis
EP1487776A4 (en) ACID COMPOUNDS AND ESTERS AND METHODS OF USE THEREOF
ZA200701233B (en) Compositions and methods for dermatological wound healing
EP1648399A4 (en) METHOD AND TOPIC COMPOSITION FOR TREATING SKIN HYPERPIGMENTATION
ZA200505679B (en) Nutritional formula comprising L(+)-lactic acid
AU2003291456A8 (en) Methods for promoting wound healing and uses thereof
IL164267A0 (en) Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase
PL376442A1 (en) Milk improved by treatment with proteases and methods for its preparation
AU2003294684A8 (en) Ketoprofen compositions and methods of making them
EP1535897A4 (en) INTERMEDIATES IN THE PRODUCTION OF PHENOXYACETIC ACID DERIVATIVES AND METHODS OF USE THEREOF
AU2003282593A8 (en) Polyphenolamine composition and method of use
EP1539707A4 (en) METHOD AND COMPOUNDS FOR PROMOTING HEALING AND INFLAMMATION REDUCTION
AU2002333157A1 (en) Compound for treatment of anxiety and methods of preparation and use thereof